RT Journal Article
SR Electronic
T1 Association of social distancing and masking with risk of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.11.20229500
DO 10.1101/2020.11.11.20229500
A1 Kwon, Sohee
A1 Joshi, Amit D.
A1 Lo, Chun-Han
A1 Drew, David A.
A1 Nguyen, Long H.
A1 Guo, Chuan-Guo
A1 Ma, Wenjie
A1 Mehta, Raaj S.
A1 Warner, Erica T.
A1 Astley, Christina M.
A1 Merino, Jordi
A1 Murray, Benjamin
A1 Wolf, Jonathan
A1 Ourselin, Sebastien
A1 Steves, Claire J.
A1 Spector, Tim D.
A1 Hart, Jaime E.
A1 Song, Mingyang
A1 VoPham, Trang
A1 Chan, Andrew T.
YR 2020
UL http://medrxiv.org/content/early/2020/11/13/2020.11.11.20229500.abstract
AB Given the continued burden of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) disease (COVID-19) across the U.S., there is a high unmet need for data to inform decision-making regarding social distancing and universal masking. We examined the association of community-level social distancing measures and individual masking with risk of predicted COVID-19 in a large prospective U.S. cohort study of 198,077 participants. Individuals living in communities with the greatest social distancing had a 31% lower risk of predicted COVID-19 compared with those living in communities with poor social distancing. Self-reported masking was associated with a 63% reduced risk of predicted COVID-19 even among individuals living in a community with poor social distancing. These findings provide support for the efficacy of mask-wearing even in settings of poor social distancing in reducing COVID-19 transmission. In the current environment of relaxed social distancing mandates and practices, universal masking may be particularly important in mitigating risk of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementZoe provided in kind support for all aspects of building, running and supporting the app and service to all users worldwide. ADJ is supported by the National Institute of Diabetes and Digestive and Kidney Diseases K01DK110267. DAD is supported by the National Institute of Diabetes and Digestive and Kidney Diseases K01DK120742. CMA is supported by the NIDDK K23-DK120899. LHN is supported by the American Gastroenterological Association Research Scholars Award. ATC is the Stuart and Suzanne Steele MGH Research Scholar and Stand Up to Cancer scientist. The Massachusetts Consortium on Pathogen Readiness (MassCPR) and Mark and Lisa Schwartz supported MGH investigators (SK, ADJ, CHL, DAD, LHN, CGG, WM, RSM, JM, ATC). King's College of London investigators (KAL, MNL, TV, MG, CHS, MJC, SO, CJS, TDS) were supported by the Wellcome Trust and EPSRC (WT212904/Z/18/Z, WT203148/Z/16/Z, T213038/Z/18/Z), the NIHR GSTT/KCL Biomedical Research Centre, MRC/BHF (MR/M016560/1), UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value Based Healthcare, and the Alzheimer's Society (AS-JF-17-011). MNL is supported by an NIHR Doctoral Fellowship (NIHR300159). JM is partially supported by the European Commission Horizon 2020 program (H2020-MSCA-IF-2015-703787) and by the National Institutes of Health (P30 DK40561). JEH is supported by NIH/NIEHS P30 ES000002. TV is supported by NIH/NIDDK K01 DK125612. Sponsors had no role in study design, analysis, and interpretation of data, report writing, and the decision to submit for publication. The corresponding author had full access to data and the final responsibility to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research study was approved by the Partners Human Research Committee (Institutional Review Board Protocol 2020P000909).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData collected in the app are being shared with other health researchers through the NHS-funded Health Data Research UK (HDRUK)/SAIL consortium, housed in the UK Secure e-Research Platform (UKSeRP) in Swansea. Anonymized data can be shared with bonafide researchers via HDRUK, provided the request is made according to their protocols and is in the public interest (see https://healthdatagateway.org/detail/9b604483-9cdc-41b2-b82c-14ee3dd705f6). Data updates can be found at https://covid.joinzoe.com.